Daniel Abdun-Nabi, President & CEO at Emergent BioSolutions Inc. (EBS), sold 21,906 shares at $47.91 ($1.0M) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $1.0M EBS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |
| EBS | SELL | 2017-12-14 | $920K | — | Filing → |